O36.099
Maternal care for other rhesus isoimmunization, unspecified trimester
Clinical Classification Guidelines
Medical Intelligence & Overview
Rhesus isoimmunization, also known as Rh incompatibility, occurs when a pregnant woman's immune system reacts against her baby's blood cells because of a difference in the Rh factor. The Rh factor is a protein that can be present on the surface of red blood cells. If a mother is Rh-negative and her baby is Rh-positive, there is a risk that her immune system will recognize the baby's blood cells as foreign and produce antibodies against them. This condition, if left unmanaged, can lead to hemolytic disease of the fetus and newborn, which can cause anemia, jaundice, or more severe complications. Maternal care for Rh isoimmunization aims to monitor and prevent these adverse effects, ensuring both maternal and fetal health throughout pregnancy.
Causes & Symptoms
Clinical Causes: Mother being Rh-negative with a previous pregnancy or blood transfusion containing Rh-positive blood Fetal blood carrying Rh-positive antigens incompatible with maternal Rh-negative blood Breaks in placental barrier allowing fetal and maternal blood to mix during pregnancy or delivery
Key Symptoms: No early symptoms; often detected through routine prenatal testing Fetal anemia leading to signs such as swelling (hydrops fetalis) Increased levels of bilirubin causing jaundice in the newborn Fetal growth restriction in severe cases Potential for miscarriage or stillbirth if untreated
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves blood tests such as direct and indirect coombs test to detect maternal antibodies against Rh-positive blood cells. Ultrasound evaluations monitor fetal well-being and detect signs of anemia or hydrops. In some cases, amniocentesis may be performed to assess fetal bilirubin levels and hemolysis. Early detection during routine prenatal visits is critical for effective management.
Treatment Protocols: Administration of Rh immunoglobulin (RhIg) injections to postpartum, after miscarriage, or invasive procedures to prevent maternal antibody formation in future pregnancies Frequent fetal monitoring through ultrasound and Doppler imaging to assess fetal health and detect anemia Intrauterine blood transfusions in severe cases to treat fetal anemia Delivery planning to optimize timing based on fetal condition, often around the time when the fetus can be safely delivered Postnatal care involving phototherapy for jaundice and treating anemia if needed
Clinical Advice & FAQs
Billing Guidance
Is O36.099 a billable ICD-10 code?
Yes, O36.099 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O36.099?
Clinical documentation must specify the nature of Maternal care for other rhesus isoimmunization, unspecified trimester and any associated comorbidities for accurate reporting.
Cite this Clinical Reference